Market Overview
ASX 200 Index
Time to Get Active on Super Collapses
$1.2B First Guardian/Shield super collapse hits 11,000 investors as deadlines loom; AFCA and Netwealth payouts underway - check if you’re affected
The Weekly Finger: Older, fitter, faster, more fragile
Markets shift as AI fuels software sector; old leadership fades while new contenders tighten their grip.
Health Insurance Costs Just Keep Rising
Australian private health insurance premiums rise 4.41% from April 1, the steepest since 2017, as cover downgrades rise and Medibank posts profits.
Silver’s Historic Rally and the Structural Deficit: Are ASX Small Caps Underappreciated?
Silver surges on structural deficit and tariff fears; ASX miners poised to benefit as supply tightens—are Australian small caps undervalued?
Weekly Wrap: ASX slips on war fears as earnings beat expectations buoy week
War fears nudge ASX 200 lower despite QBE's 21% profit surge; energy gains lift oil names, tech slumps; Guzman sinks below float.
ANZ Soars and AMP Sinks: Earnings Breakdown
ANZ delivers $1.9b cash profit in Q1, 3bp NIM uplift, and cost discipline driving outperformance as Feb earnings season kicks off (AMP results due).
CBA Up 8%: Double Down on NAB or Add Small Caps PPM, JDO?
CBA jumps 8% to above $171, reigniting the Big Four debate as rivals rally; strong profit, higher dividend, and rich multiples raise the risk-reward for banks.
Weekly Wrap: Markets edge as Rio-Glencore talks spark change in mining bid
Rio Tinto slides 6% on Glencore all-stock merger talks; BlueScope up 2% after rejecting a $30 offer. ASX 200 drifts -0.1% as deal news dominates.
Anax Metals Reinforces Outstanding Economics with Whim Creek DFS
Anax Metals' Whim Creek DFS flags base-case NPV7 A$501m, IRR 98% (spot 118%/A$649m); ~A$723m cash flow over 10 years; 12–14 month payback; funding crucial.
Dreadnought Resources Adds High Range Northwest Prospect to Mangaroon Gold Project
Dreadnought Resources adds High Range Northwest to Mangaroon gold project after strong gold-in-stream anomalies; now seven camp-scale prospects.
Red Mountain Mining Continues Push to Advance US and Australian Critical Minerals Portfolio
Red Mountain Mining (ASX: RMX) pushes ahead in US-Australian critical minerals with Thompson Falls antimony acquisition, high-grade assays and expansion plans.
European Resources Confirms Standout 31.5m Intersection at Korsnäs Project in Finland
European Resources logs 31.5m at Korsnäs with 4,902ppm TREO (NdPr-enriched); southern target validated, spotlighting Korsnäs as Europe’s REE hub.
Radiopharm Theranostics Doses First Patient in RV-01 Phase 1/2a Trial for Aggressive Cancers
RAD doses first patient in RV-01 Phase 1/2a trial for aggressive cancers, a 177Lu-radiotherapeutic targeting B7-H3, to define dose for future studies.
Lumos Diagnostics Achieves BARDA Paediatric Study Milestone, Secures US$720k Payment
Lumos Diagnostics hits BARDA Milestone 6, secures US$720k non-dilutive payment as FebriDx paediatric study advances toward FDA submission and wider US TAM.
Little Green Pharma to Divest WA Production Site in $7.8 Million Sale and Lease-Back Deal
LGP to sell WA production site for $7.8m in a sale-and-lease-back to fund Australian and European expansion; settlement targeted mid-March 2026.
Cyclopharm Secures NIH Approval for Technegas, Boosting US Expansion
Cyclopharm wins NIH approval for Technegas, secures US purchase order; installation under FSS imminent as funding targets 250-300 US installs by H2 2026.
Spacetalk Executes Strategic MOU with Vodafone Australia for Family Safety Software
Spacetalk signs 12-month MOU with Vodafone Australia via TPG to distribute Family Safety software to postpaid customers, targeting $20-25m ARR by CY2026.
Nuix Reports Strong 1H26 with Neo Growth and Linkurious Acquisition
Nuix 1H26: ACV +8.4% to A$234.4m, Neo ACV +148%, revenue +15.2%, FY26 guidance reaffirmed; to acquire Linkurious for up to €20m.
Aerometrex Posts Record H1 Revenue and EBITDA as MetroMap ACV Jumps
Aerometrex posts record 1H26 revenue of $12.93m and EBITDA of $3.55m, as MetroMap ACV surges 35% and LiDAR revenue rebounds—signaling upside.
Synertec Secures Sydney Water Projects Exceeding $1m, Tapping into $245m Pipeline
Synertec (ASX:SOP) lands $1m Sydney Water OT contracts, tapping a $245m pipeline; Sydney office and State Manager to speed delivery across Greater Sydney.
Bass Oil Awarded $3.5m SA Government Grant for Kiwi Gas Project
Bass Oil (ASX: BAS) awarded $3.5m SA government grant for Kiwi liquids-rich gas project; pipeline to Cooper Basin; online by end-2028.
Elixir Energy Delivers Outstanding Results at Lorelle-3, Unveiling Significant Gas-Condensate Reservoirs
Elixir Energy (ASX: EXR) reports Lorelle-3: four gas-condensate reservoirs, northward Dunk extension; boosting Taroom Trough maiden reserves; 2026 flow tests.
Prominence Energy Kicks Off Field Work in PEL 803 with Geochemical Survey for Natural Hydrogen
Prominence Energy (ASX: PRM) has initiated its first field exploration for natural hydrogen and helium with a geochemical survey in South Australia's PEL 803.
Blue Star Helium's Galactica Project Poised for Integrated Operations Next Week
Blue Star Helium (BNL) is poised to commence integrated operations at its Galactica project next week, with the CO2 amine unit now online.
ClearView Wealth Receives $415m Takeover Bid from Zurich Insurance Group
ClearView Wealth (CVW) faces a $415m takeover bid from Zurich; cash $0.65/share (~20% vs 3m VWAP, ~26% vs 12m VWAP) — board unanimously backs the scheme.
Cash Converters International Reports Strong H1 FY2026 Results as EBITDA Surges 18%
Cash Converters (ASX: CCV) H1 FY2026: revenue A$206.7m, EBITDA +18% to A$34.2m; Cashies Loan growth, 40+ store acquisitions, dividend maintained.
Sports Entertainment Group Posts Strong H1 FY26, Raises FY26 Guidance
SEG beats H1 FY26, revenue $73.7m, EBITDA up 78% to $11.9m; upgrades FY26 EBITDA growth to at least 40% after Perth Wildcats sale nets $12m cash.
Solvar H1 FY26 NPAT Rises 5.8% Amid NZ Exit and Funding Boost
Solvar NPAT up 5.8% in H1 FY26 as it accelerates NZ exit, secures $488m warehouse facility, boosting funding to ~$1.1b and announcing dividends.
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]
Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]
ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]